YU54503A - Farmaceutski sastav koji sadrži citalopram - Google Patents
Farmaceutski sastav koji sadrži citalopramInfo
- Publication number
- YU54503A YU54503A YU54503A YUP54503A YU54503A YU 54503 A YU54503 A YU 54503A YU 54503 A YU54503 A YU 54503A YU P54503 A YUP54503 A YU P54503A YU 54503 A YU54503 A YU 54503A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- pharmaceutical composition
- composition containing
- citalopram
- containing citalopram
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Čvrsti jedinični oblik doze koji obuhvata citalopram koji je pripremljen postupkom koji obuhvata korak gde su citalopram baza ili njegova farmaceutski prihvatljiva so i opciono farmaceutski prihvatiljivi inertni punioci presovani valjkom.[A solid unit dosage form comprising citalopram which is prepared by a process comprising a step wherein citalopram base or a pharmaceutically acceptable salt and optionally pharmaceutically acceptable excipients is roller compacted.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200100016 | 2001-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU54503A true YU54503A (sh) | 2006-05-25 |
Family
ID=8159961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU54503A YU54503A (sh) | 2001-01-05 | 2002-01-03 | Farmaceutski sastav koji sadrži citalopram |
Country Status (22)
Country | Link |
---|---|
US (1) | US20040058989A1 (sh) |
EP (1) | EP1351667A1 (sh) |
JP (1) | JP2004517111A (sh) |
KR (1) | KR20030070088A (sh) |
CN (1) | CN1484523A (sh) |
AU (1) | AU2001100195B4 (sh) |
BG (1) | BG108034A (sh) |
BR (1) | BR0206272A (sh) |
CA (1) | CA2358356A1 (sh) |
CZ (1) | CZ20032119A3 (sh) |
EA (1) | EA005596B1 (sh) |
HR (1) | HRP20030546A2 (sh) |
HU (1) | HUP0302531A3 (sh) |
IL (1) | IL156547A0 (sh) |
IS (1) | IS6857A (sh) |
MX (1) | MXPA03005965A (sh) |
NO (1) | NO20033073D0 (sh) |
PL (1) | PL362358A1 (sh) |
SK (1) | SK9912003A3 (sh) |
WO (1) | WO2002053133A1 (sh) |
YU (1) | YU54503A (sh) |
ZA (1) | ZA200304860B (sh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2406592C (en) * | 2002-10-04 | 2003-09-30 | Duchesnay Inc. | Method of preparing pharmaceutical dosage forms containing multiple active ingredients |
NZ542303A (en) * | 2003-03-14 | 2008-12-24 | Nirmal Mulye | A process for preparing sustained release tablets |
HU227491B1 (en) * | 2003-11-25 | 2011-07-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Tablet containing citalopram hydrogen bromide |
EP1901714A2 (en) * | 2005-05-20 | 2008-03-26 | Aurobindo Pharma Limited | Pharmaceutical dosage forms comprising escitalopram in form of granules |
CN100353939C (zh) * | 2006-01-05 | 2007-12-12 | 昆明积大制药有限公司 | 含西酞普兰和环糊精的抗抑郁口服药用组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1358915A (en) * | 1971-09-13 | 1974-07-03 | Merck & Co Inc | Directly compressed tablet and composition therefor |
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
US6977306B2 (en) * | 2000-05-02 | 2005-12-20 | Sumitomo Chemical Company, Limited | Citalopram hydrobromide crystal and method for crystallization thereof |
IS6021A (is) * | 2000-08-10 | 2001-10-20 | H. Lundbeck A/S | Lyfjasamsetningar sem innihalda sítalópram |
-
2001
- 2001-07-26 AU AU2001100195A patent/AU2001100195B4/en not_active Ceased
- 2001-10-04 CA CA002358356A patent/CA2358356A1/en not_active Abandoned
-
2002
- 2002-01-03 MX MXPA03005965A patent/MXPA03005965A/es unknown
- 2002-01-03 EP EP02726983A patent/EP1351667A1/en not_active Withdrawn
- 2002-01-03 KR KR10-2003-7008953A patent/KR20030070088A/ko not_active Application Discontinuation
- 2002-01-03 WO PCT/DK2002/000003 patent/WO2002053133A1/en not_active Application Discontinuation
- 2002-01-03 JP JP2002554084A patent/JP2004517111A/ja not_active Withdrawn
- 2002-01-03 CZ CZ20032119A patent/CZ20032119A3/cs unknown
- 2002-01-03 HU HU0302531A patent/HUP0302531A3/hu unknown
- 2002-01-03 BR BR0206272-0A patent/BR0206272A/pt not_active IP Right Cessation
- 2002-01-03 SK SK991-2003A patent/SK9912003A3/sk unknown
- 2002-01-03 YU YU54503A patent/YU54503A/sh unknown
- 2002-01-03 IL IL15654702A patent/IL156547A0/xx unknown
- 2002-01-03 CN CNA028034686A patent/CN1484523A/zh active Pending
- 2002-01-03 EA EA200300768A patent/EA005596B1/ru not_active IP Right Cessation
- 2002-01-03 PL PL02362358A patent/PL362358A1/xx not_active Application Discontinuation
-
2003
- 2003-06-23 IS IS6857A patent/IS6857A/is unknown
- 2003-06-23 ZA ZA200304860A patent/ZA200304860B/en unknown
- 2003-07-01 US US10/619,743 patent/US20040058989A1/en not_active Abandoned
- 2003-07-04 NO NO20033073A patent/NO20033073D0/no not_active Application Discontinuation
- 2003-07-04 HR HR20030546A patent/HRP20030546A2/xx not_active Application Discontinuation
- 2003-07-28 BG BG108034A patent/BG108034A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
CN1484523A (zh) | 2004-03-24 |
JP2004517111A (ja) | 2004-06-10 |
EA005596B1 (ru) | 2005-04-28 |
NO20033073L (no) | 2003-07-04 |
KR20030070088A (ko) | 2003-08-27 |
PL362358A1 (en) | 2004-10-18 |
NO20033073D0 (no) | 2003-07-04 |
EA200300768A1 (ru) | 2003-10-30 |
ZA200304860B (en) | 2004-06-30 |
MXPA03005965A (es) | 2003-09-05 |
HUP0302531A2 (hu) | 2003-11-28 |
SK9912003A3 (en) | 2003-12-02 |
WO2002053133A1 (en) | 2002-07-11 |
HRP20030546A2 (en) | 2005-06-30 |
CA2358356A1 (en) | 2002-01-20 |
AU2001100195A4 (en) | 2001-08-16 |
BR0206272A (pt) | 2003-12-30 |
AU2001100195B4 (en) | 2001-12-20 |
HUP0302531A3 (en) | 2007-06-28 |
EP1351667A1 (en) | 2003-10-15 |
BG108034A (bg) | 2005-02-28 |
IL156547A0 (en) | 2004-01-04 |
IS6857A (is) | 2003-06-23 |
US20040058989A1 (en) | 2004-03-25 |
CZ20032119A3 (en) | 2004-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20074047B (en) | Pramipexole once-daily dosage form | |
MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
NZ514574A (en) | Novel method of treatment | |
IL180710A0 (en) | Controlled-release, injectable pharmaceutical implant | |
MY126555A (en) | Oral pharmaceutical extended release dosage form | |
PL356358A1 (en) | Solid dosage form of someticone for oral administration | |
IL154012A0 (en) | Hydrogel-driven drug dosage form | |
CA2427815A1 (en) | Controlled release hydrocodone formulations | |
NZ527832A (en) | Chronotherapeutic dosage forms | |
HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
AP1954A (en) | Controlled release compositions comprising nimesulide. | |
MXPA03009391A (es) | METODO PARA FABRICAR UNA COMPOSICIoN FARMACEUTICA DE DOSIS BAJA. | |
GB0017060D0 (en) | Production, stabilisation and use of reduced forms of pharmaceutical compounds | |
TW200509905A (en) | Pharmaceutical compositions of atorvastatin | |
ATE252377T1 (de) | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff | |
SG116507A1 (en) | Pharmaceutical dosage form and method of making. | |
ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
HUP0302050A3 (en) | Pharmaceutical form of administration for peptides, method for its production and use | |
GR20010100377A (el) | Φαρμακευτικη συνθεση περιεχουσα σιταλοπραμη | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
YU54503A (sh) | Farmaceutski sastav koji sadrži citalopram | |
CA2432177A1 (en) | Drug for prevention and/or therapy of endometriosis | |
TW200500085A (en) | Sustained-release pharmaceutical composition for lung administration | |
AU3547001A (en) | Method for producing pharmaceutical dosage forms | |
PL1499278T3 (pl) | Farmaceutyczna postać użytkowa o natychmiastowym uwalnianiu zawierająca polimorficzny tibolon |